Rhinostop Spray nasal 0.05% 15 ml
Condition: New product
1000 Items
Rating:
Be the first to write a review!
More info
Active ingredients
Xylometazoline
Release form
Spray
Composition
The composition of 1 ml: Active ingredient: Xylometazoline hydrochloride - 0.50 mg; Excipients: disodium edetate (Trilon B) - 0.50 mg, sodium chloride - 9.00 mg, benzalkonium chloride - 0.15 mg, potassium dihydrogen phosphate - 3.63 mg, sodium hydrogen phosphate dodecahydrate - 7.13 mg, purified water - up to 1 ml.
Pharmacological effect
Xylometazoline belongs to the group of local vasoconstrictor agents (decongestants) with alpha adrenomimetic activity, causes narrowing of the blood vessels of the nasal mucosa, thus eliminating the swelling and hyperemia of the nasal mucosa, restores the nasal passability, facilitates nasal breathing. The effect of the drug occurs within a few minutes after its use and lasts up to 10 hours.
Pharmacokinetics
When applied topically, the drug is practically not absorbed, therefore its concentration in the blood plasma is very low (it is not determined by modern analytical methods).
Indications
Applied with acute respiratory diseases with symptoms of rhinitis (runny nose), acute allergic rhinitis, sinusitis, with otitis media (as part of combination therapy to reduce swelling of the nasopharyngeal mucosa). Preparing the patient for diagnostic manipulations in the nasal passages.
Contraindications
Hypersensitivity to xylometazoline, arterial hypertension, tachycardia, marked atherosclerosis, glaucoma, atrophic rhinitis, surgery on the meninges (in history), children (up to 2 years - for 0.05% spray, up to 6 years for 0.1% spray), pregnancy. Do not use in the treatment of monoamine oxidase inhibitors and tricyclic antidepressants.
Precautionary measures
With caution Diabetes, hyperthyroidism, coronary heart disease (angina), prostatic hyperplasia, lactation.
Use during pregnancy and lactation
During pregnancy, the use of the drug is contraindicated. During lactation, the drug should be used only as prescribed by a doctor, after a thorough assessment of the risk-benefit ratio for mother and child. It is not allowed to exceed the recommended dosage.
Dosage and administration
Intranasal. Spraying is done after removing the protective cap from the sprayer.The nebulizer is introduced into the nose and, pressing on its base, sprayed for 1 second. For adults and children over the age of 6 years (0.1% spray): one injection from the nebulizer into each nasal passage, usually 3-4 injections per day are enough; should not be applied more than 3 times a day. For children aged 2 to 6 years (0.05% spray), one injection from the nebulizer into each nasal passage 1 or 2 times a day; should not be applied more than 3 times a day. Do not use the drug without a break for more than 3-5 days. During the introduction of the drug should keep the bottle spray up!
Side effects
With frequent and / or long-term use - irritation and / or dryness of the nasal mucosa, burning and paresthesia of the nasal mucosa, sneezing, hypersecretion of the nasal mucosa; swelling of the nasal mucosa, vomiting, headache, feeling of heartbeat, high blood pressure, tachycardia, arrhythmia, insomnia, blurred vision, depression (with prolonged use of high doses).
Overdose
Symptoms: increased side effects, including increased blood pressure, which leads to a reduction in blood pressure, bradycardia, a decrease in body temperature. Treatment: symptomatic under medical supervision.
Interaction with other drugs
It is possible to enhance the systemic action with simultaneous use of monoamine oxidase inhibitors and tricyclic antidepressants.
special instructions
It should not be used for a long time (more than 7 days), for example, in chronic rhinitis. Avoid getting the drug in the eye (the drug affects the vision).